Adiponectin Reduces Bone Stiffness: Verified in a Three-Dimensional Artificial Human Bone Model In Vitro.

about

Adiponectin Reduces Bone Stiffness: Verified in a Three-Dimensional Artificial Human Bone Model In Vitro.

Item

http://www.wikidata.org/entity/Q55021030

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Adiponectin Reduces Bone Stiff ...... ial Human Bone Model In Vitro.

@en

Adiponectin Reduces Bone Stiff ...... ial Human Bone Model In Vitro.

@nl

type

Item

label

Adiponectin Reduces Bone Stiff ...... ial Human Bone Model In Vitro.

@en

Adiponectin Reduces Bone Stiff ...... ial Human Bone Model In Vitro.

@nl

prefLabel

Adiponectin Reduces Bone Stiff ...... ial Human Bone Model In Vitro.

@en

Adiponectin Reduces Bone Stiff ...... ial Human Bone Model In Vitro.

@nl

P1476

Adiponectin Reduces Bone Stiff ...... ial Human Bone Model In Vitro.

@en

P2093

Alamelu Sundaresan

http://www.w3.org/2001/XMLSchema#string

Bjørn Skallerud

http://www.w3.org/2001/XMLSchema#string

Janne Elin Reseland

http://www.w3.org/2001/XMLSchema#string

Kristin Matre Aasarød

http://www.w3.org/2001/XMLSchema#string

Sigrid Haugen

http://www.w3.org/2001/XMLSchema#string

Unni Syversen

http://www.w3.org/2001/XMLSchema#string

P2860

NIH Image to ImageJ: 25 years of image analysis

Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

A novel serum protein similar to C1q, produced exclusively in adipocytes

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome

Adiponectin and AMP kinase activator stimulate proliferation, differentiation, and mineralization of osteoblastic MC3T3-E1 cells

Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)alpha agonist fenofibrate and the PPARgamma agonist pioglitazone.

Central adiponectin administration reveals new regulatory mechanisms of bone metabolism in mice

The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats

P304

236

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FENDO.2018.00236

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hanna Tiainen

Jianying He

Astrid K. Stunes

P577

2018-05-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29867768

http://www.w3.org/2001/XMLSchema#string

P932

5960720

http://www.w3.org/2001/XMLSchema#string